CHIH Global X MSCI China Health Care ETF
MSCI China Health Care 10/50 NR USD

NAV as of 02-Dec-2022

15.9300

4 Week: 14.79 - 16.56

52 Week: 12.54 - 23.59

Latest Closing Price

16.26

Premium / Discount

1.56

Expense Ratio

0.65%

Investment Objective

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI China Health Care 10/50 Index. The fund invests at least 80% of its total assets in the securities of the underlying index and in ADRs and GDRs based on the securities in the underlying index. The underlying index tracks the performance of companies in the MSCI China Index (the "parent index") that are classified in the health care sector, as defined by the index provider. The fund is non-diversified.

Main Fund Characteristics

Fund Manager:
Global X Funds
Asset Under Management:
9,583,535
Launch Date:
06/12/2018
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
80
Trading Currency:
USD
Style:
Large Growth
Region/Sector/Strategy:
China / N.A / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-24.962.62-9.53
1 Day1.180.000.00
1 Week8.404.281.96
1 Month11.6411.201.04
3 Months6.0722.450.27
6 Months8.4727.580.31
1 Year-29.6641.53-0.71
2 Years-30.6853.24-0.58
3 Years-2.6462.51-0.04
5 Years0.000.000.00
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.00000.00000.00000.00000.000031.718952.7628-19.3836
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.000040.000025.000077.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
N.A

Portfolio Data

Total Number of Holdings: 80

Number of Bond Holdings: 0

Number of Equity Holdings: 80

Total Market Value: 9,583,535

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1CSPC Pharmaceutical Group Ltd12.7273130,0000345,050
2Sino Biopharmaceutical Ltd9.8158171,5000266,117
3WuXi Biologics (Cayman) Inc Registered Shs Unitary8.055619,7400218,394
4Sinopharm Group Co Ltd H6.724751,3000182,313
5Alibaba Health Information Technology Ltd6.1249158,5000166,053
63SBio Inc4.315660,4000116,999
7Shandong Weigao Group Medical Polymer Co Ltd Class4.176197,5000113,219
8Genscript Biotech Corp Class H4.113843,7000111,529
9Jiangsu Hengrui Medicine Co Ltd3.82267,9000103,635
10China Medical System Holdings Ltd3.573069,900096,868

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant31.68
Large53.12
Medium13.53
Small2.70
Micro0.00

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

17.3009

Price/Book*

2.7448

Price/Sales*

1.3887

Price/Cash Flow*

13.7470

Dividend Yield*

1.2787

Growth Measures

Long-Term Earnings

15.7732

Historical Earnings

26.6547

Sales Growth

15.7024

Cash-Flow Growth

24.0083

Book-Value Growth

14.6962

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.